middle.news
Amplia Advances Pancreatic Cancer Fight with US Ethics Nod for New Trial
8:37am on Tuesday 24th of June, 2025 AEST
•
Healthcare
Read Story
Amplia Advances Pancreatic Cancer Fight with US Ethics Nod for New Trial
8:37am on Tuesday 24th of June, 2025 AEST
Key Points
US Institutional Review Board grants ethics approval for Phase 2 trial
Trial to test narmafotinib combined with FOLFIRINOX chemotherapy
Study sites planned across the US and Australia
Trial aims to identify optimal narmafotinib dosing with FOLFIRINOX
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Amplia Therapeutics (ASX:ATX)
OPEN ARTICLE